Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

SELL
$155.75 - $174.48 $528,148 - $591,661
-3,391 Reduced 59.27%
2,330 $362,000
Q2 2023

Jul 13, 2023

BUY
$154.35 - $166.11 $44,915 - $48,338
291 Added 5.36%
5,721 $946,000
Q1 2023

Apr 24, 2023

BUY
$151.05 - $180.26 $1,510 - $1,802
10 Added 0.18%
5,430 $852,000
Q4 2022

Feb 06, 2023

SELL
$160.2 - $179.79 $25,792 - $28,946
-161 Reduced 2.88%
5,420 $966,000
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $34,685 - $38,596
-215 Reduced 3.71%
5,581 $911,000
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $46,252 - $51,152
-275 Reduced 4.53%
5,796 $1.04 Million
Q1 2022

Apr 25, 2022

SELL
$158.14 - $179.59 $220,605 - $250,528
-1,395 Reduced 18.68%
6,071 $1.1 Million
Q4 2021

Jan 31, 2022

BUY
$155.93 - $173.01 $1.16 Million - $1.29 Million
7,466 New
7,466 $1.27 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Dmg Group, LLC Portfolio

Follow Dmg Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.